fda glp-1 compounding enforcement september 2025 8, 2025: launches an import alert listing safe manufacturers – Partnership for Safe Medicines FDA Drug Recalls and Warnings:

Mechanism In response to a previous FDA inquiry, two short-term mechanical studies were conducted using exenatide and liraglutide in a diabetic rat model, wherein one rat administered with exenatide died of pancreatic necrosis, while the others exhibited acinar-to-ductal metaplasia and ductal hyperplasia, indicative of potential premalignant alterations [62,63]

New study: 1 in 5 GLP-1 users develop nutritional deficiencies This week, I'm unpacking a brand new study by Butsch et al

Proper injection technique is crucial to ensure the medication is administered correctly and to minimize potential injection site reactions

The potential mechanisms through which GLP-1 and GIP/GLP-1 receptor agonists recalibrate and normalize the fat mass and body weight setpoint in patients with obesity may stem from their primary effects on incretin homeostasis

Other devices such as intra-gastric balloons to induce early satiety are under study

Diana Girnita Dr